Thomas George named interim director of UF Health Cancer Institute

Christine Lovly to lead City of Hope’s new national thoracic oncology program

Christine M. Lovly will spearhead the development of City of Hope’s new national thoracic oncology program, effective Jan. 1, 2026.

November 14, 2025

Vol.51 No.42

In Brief

The Alliance for Clinical Trials in Oncology appoints new committee leaders

The Alliance for Clinical Trials in Oncology has named new investigators to leadership roles across its Immuno-Oncology, Radiation Oncology, and Imaging Committees. These accomplished leaders bring expertise spanning immunotherapy, breast, and brain cancers, precision radiotherapy, and advanced imaging technologies.

November 07, 2025

Vol.51 No.41

In Brief

Michael Deininger, Lesly Dossett, Samuel Kaffenberger join Rogel Cancer Center leadership

The University of Michigan Rogel Cancer has named two new deputy directors and a new associate director to provide strategic leadership in cancer care, research, and training

November 07, 2025

Vol.51 No.41

In Brief

Azeddine Atfi, Elizabeth Cunningham, Benjamin Herring appointed to Karmanos leadership

Azeddine AtfiElizabeth CunninghamBenjamin HerringThe Barbara Ann Karmanos Cancer Institute has appointed Azeddine Atfi as deputy center director of research, Elizabeth Cunningham as vice president of the Karmanos Cancer Institute Clinical Trials Office, and Benjamin Herring as vice president and associate center director of research administration.

November 07, 2025

Vol.51 No.41

In Brief

Richard Schulick named chief clinical officer at University of Rochester Medical Center

Richard Schulick was named chief clinical officer at University of Rochester Medical Center, effective April 2026. Schulick will also become senior vice president for health system strategy, and vice dean for clinical affairs.

November 07, 2025

Vol.51 No.41